These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 34387015)
21. Substrate Fragmentation for the Design of M. tuberculosis CYP121 Inhibitors. Kavanagh ME; Gray JL; Gilbert SH; Coyne AG; McLean KJ; Davis HJ; Munro AW; Abell C ChemMedChem; 2016 Sep; 11(17):1924-35. PubMed ID: 27432475 [TBL] [Abstract][Full Text] [Related]
22. Hit discovery of Mycobacterium tuberculosis inosine 5'-monophosphate dehydrogenase, GuaB2, inhibitors. Sahu NU; Singh V; Ferraris DM; Rizzi M; Kharkar PS Bioorg Med Chem Lett; 2018 Jun; 28(10):1714-1718. PubMed ID: 29699922 [TBL] [Abstract][Full Text] [Related]
23. The pup-proteasome system of Mycobacterium tuberculosis. Samanovic MI; Li H; Darwin KH Subcell Biochem; 2013; 66():267-95. PubMed ID: 23479444 [TBL] [Abstract][Full Text] [Related]
24. A consensus reverse docking approach for identification of a competitive inhibitor of acetyltransferase enhanced intracellular survival protein from Mycobacterium tuberculosis. Santos-Júnior PFDS; Batista VM; Nascimento IJDS; Nunes IC; Silva LR; Costa CACB; Freitas JD; Quintans-Júnior LJ; Araújo-Júnior JX; Freitas MEG; Zhan P; Green KD; Garneau-Tsodikova S; Mendonça-Júnior FJB; Rodrigues-Junior VS; Silva-Júnior EFD Bioorg Med Chem; 2024 Jun; 108():117774. PubMed ID: 38833750 [TBL] [Abstract][Full Text] [Related]
25. Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis. Pedgaonkar GS; Sridevi JP; Jeankumar VU; Saxena S; Devi PB; Renuka J; Yogeeswari P; Sriram D Eur J Med Chem; 2014 Oct; 86():613-27. PubMed ID: 25218910 [TBL] [Abstract][Full Text] [Related]
26. Pupylation : A Signal for Proteasomal Degradation in Mycobacterium tuberculosis. Burns KE; Darwin KH Subcell Biochem; 2010; 54():149-57. PubMed ID: 21222280 [TBL] [Abstract][Full Text] [Related]
27. A kinetic model for the prevalence of mono- over poly-pupylation. Regev O; Roth Z; Korman M; Khalaila I; Gur E FEBS J; 2015 Nov; 282(21):4176-86. PubMed ID: 26277445 [TBL] [Abstract][Full Text] [Related]
28. A time-resolved Förster resonance energy transfer assay to measure activity of the deamidase of the prokaryotic ubiquitin-like protein. Eustis IC; Huang J; Pilkerton ME; Whedon SD; Chatterjee C Anal Biochem; 2015 Oct; 487():27-9. PubMed ID: 26205584 [TBL] [Abstract][Full Text] [Related]
29. Identification of Mycobacterium tuberculosis CtpF as a target for designing new antituberculous compounds. Santos P; Lopez-Vallejo F; Ramírez D; Caballero J; Mata Espinosa D; Hernández-Pando R; Soto CY Bioorg Med Chem; 2020 Feb; 28(3):115256. PubMed ID: 31879181 [TBL] [Abstract][Full Text] [Related]
30. Discovery and Mechanistic Study of Li C; Liu S; Dong B; Li C; Jian L; He J; Zeng J; Zhou Q; Jia D; Luo Y; Sun Q J Med Chem; 2022 Aug; 65(16):11058-11065. PubMed ID: 35926511 [TBL] [Abstract][Full Text] [Related]
31. Monocarbonyl analogs of curcumin inhibit growth of antibiotic sensitive and resistant strains of Mycobacterium tuberculosis. Baldwin PR; Reeves AZ; Powell KR; Napier RJ; Swimm AI; Sun A; Giesler K; Bommarius B; Shinnick TM; Snyder JP; Liotta DC; Kalman D Eur J Med Chem; 2015 Mar; 92():693-9. PubMed ID: 25618016 [TBL] [Abstract][Full Text] [Related]
32. 5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies. Sriram D; Yogeeswari P; Senthilkumar P; Naidu G; Bhat P J Enzyme Inhib Med Chem; 2010 Dec; 25(6):765-72. PubMed ID: 20569083 [TBL] [Abstract][Full Text] [Related]
33. Mycobacterial ubiquitin-like protein ligase PafA follows a two-step reaction pathway with a phosphorylated pup intermediate. Guth E; Thommen M; Weber-Ban E J Biol Chem; 2011 Feb; 286(6):4412-9. PubMed ID: 21081505 [TBL] [Abstract][Full Text] [Related]
34. The Mechanism of Mycobacterium smegmatis PafA Self-Pupylation. Chen X; Li C; Wang L; Liu Y; Li C; Zhang J PLoS One; 2016; 11(3):e0151021. PubMed ID: 26953889 [TBL] [Abstract][Full Text] [Related]
35. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase. Baig IA; Moon JY; Lee SC; Ryoo SW; Yoon MY Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243 [TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors. Samala G; Devi PB; Saxena S; Meda N; Yogeeswari P; Sriram D Bioorg Med Chem; 2016 Mar; 24(6):1298-307. PubMed ID: 26867485 [TBL] [Abstract][Full Text] [Related]
37. Identification of inhibitors targeting polyketide synthase 13 of Mycobacterium tuberculosis as antituberculosis drug leads. Wang X; Zhao W; Wang B; Ding W; Guo H; Zhao H; Meng J; Liu S; Lu Y; Liu Y; Zhang D Bioorg Chem; 2021 Sep; 114():105110. PubMed ID: 34175719 [TBL] [Abstract][Full Text] [Related]
38. Prokaryotic Ubiquitin-Like Protein and Its Ligase/Deligase Enyzmes. Delley CL; Müller AU; Ziemski M; Weber-Ban E J Mol Biol; 2017 Nov; 429(22):3486-3499. PubMed ID: 28478282 [TBL] [Abstract][Full Text] [Related]
39. The Pup-Proteasome System of Mycobacteria. Bode NJ; Darwin KH Microbiol Spectr; 2014 Oct; 2(5):. PubMed ID: 26104367 [TBL] [Abstract][Full Text] [Related]
40. Structure-Guided Optimization of Inhibitors of Acetyltransferase Eis from Punetha A; Ngo HX; Holbrook SYL; Green KD; Willby MJ; Bonnett SA; Krieger K; Dennis EK; Posey JE; Parish T; Tsodikov OV; Garneau-Tsodikova S ACS Chem Biol; 2020 Jun; 15(6):1581-1594. PubMed ID: 32421305 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]